Immunological markers that predict radiation toxicity

被引：53
作者：
Sprung, Carl N. [1 ,2 ]
Forrester, Helen B. [1 ,2 ]
Siva, Shankar [3 ,4 ]
Martin, Olga A. [3 ,4 ,5 ]
机构：
[1] MIMR PHI Inst Med Res, Ctr Innate Immunol & Infect Dis, Clayton, Vic 3168, Australia
[2] Monash Univ, Dept Mol & Translat Sci, Clayton, Vic, Australia
[3] Peter MacCallum Canc Ctr, Div Radiat Oncol & Canc Imaging, Melbourne, Vic, Australia
[4] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia
[5] Peter MacCallum Canc Ctr, Mol Radiat Biol Lab, Melbourne, Vic, Australia
来源：
CANCER LETTERS | 2015年 / 368卷 / 02期
基金：
英国医学研究理事会; 美国国家卫生研究院;
关键词：
Radiation sensitivity; Immunology; Biomarker; Radiotherapy; Inflammation; GROWTH-FACTOR-BETA; INDUCED PULMONARY-FIBROSIS; GENE-EXPRESSION PROFILE; NORMAL TISSUE-REACTIONS; NF-KAPPA-B; CANCER-PATIENTS; LUNG-CANCER; RADIOTHERAPY; DAMAGE; CELLS;
D O I：
10.1016/j.canlet.2015.01.045
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Radiotherapy is a major modality of cancer treatment responsible for a large proportion of cancer that is cured. Radiation exposure induces an inflammatory response which can be influenced by genetic, epigenetic, tumour, health and other factors which can lead to very different treatment outcomes between individuals. Molecules involved in the immunological response provide excellent potential biomarkers for the prediction of radiation-induced toxicity. The known molecular and cellular immunological responses in relation to radiation and the potential to improve cancer treatment are presented in this review. In particular, immunological biomarkers of radiation-induced fibrosis and pneumonitis in cancer radiotherapy patients are discussed. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：191 / 197
页数：7
相关论文
共 95 条
  • [11] Cancer and Radiation Therapy: Current Advances and Future Directions
    Baskar, Rajamanickam
    Lee, Kuo Ann
    Yeo, Richard
    Yeoh, Kheng-Wei
    [J]. INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2012, 9 (03): : 193 - 199
  • [12] Belot J., 1905, Radiotherapy in skin disease
  • [13] Interleukin (IL)-1A and IL-6: Applications to the predictive diagnostic testing of radiation pneumonitis
    Chen, YY
    Hyrien, O
    Williams, J
    Okunieff, P
    Smudzin, T
    Rubin, P
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (01): : 260 - 266
  • [14] Circulating IL-6 as a predictor of radiation pneumonitis
    Chen, YY
    Rubin, P
    Williams, J
    Hernady, E
    Smudzin, T
    Okunieff, P
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 49 (03): : 641 - 648
  • [15] Radiation pneumonitis and early circulatory cytokine markers
    Chen, YY
    Williams, J
    Ding, I
    Hernady, E
    Liu, WM
    Smudzin, T
    Finkelstein, JN
    Rubin, P
    Okunieff, P
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (01) : 26 - 33
  • [16] Nijmegen breakage syndrome (NBS)
    Chrzanowska, Krystyna H.
    Gregorek, Hanna
    Dembowska-Baginska, Bozenna
    Kalina, Maria A.
    Digweed, Martin
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2012, 7
  • [17] CCL2 (monocyte chemoattractant protein-1) and cancer
    Conti, I
    Rollins, BJ
    [J]. SEMINARS IN CANCER BIOLOGY, 2004, 14 (03) : 149 - 154
  • [18] Cytokines in bronchoalveolar lavage fluid and serum of lung cancer patients during radiotherapy - Association of interleukin-8 and VEGF with survival
    Crohns, Marika
    Saarelainen, Seppo
    Laine, Seppo
    Poussa, Tuija
    Alho, Hannu
    Kellokumpu-Lehtinen, Pirkko
    [J]. CYTOKINE, 2010, 50 (01) : 30 - 36
  • [19] Significance of plasma transforming growth factor-β levels in radiotherapy for non-small-cell lung cancer
    De Jaeger, K
    Seppenwoolde, Y
    Kampinga, HH
    Boersma, LJ
    Belderbos, JSA
    Lebesque, JV
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (05): : 1378 - 1387
  • [20] The role of radiotherapy in cancer treatment - Estimating optimal utilization from a review of evidence-based clinical guidelines
    Delaney, G
    Jacob, S
    Featherstone, C
    Barton, M
    [J]. CANCER, 2005, 104 (06) : 1129 - 1137
12345678910